Sign In
Buy LLY
$1,192.80
+22.94 (+1.96%)
At Close: Aug 06, 2026
Focus: Lilly weight-loss pill could be FDA-approved by year-end
06:09am, Tuesday, 16'th Sep 2025
Eli Lilly 's experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched by the U.S. Food and Drug Administration, several Wall Street analysts said.
Here Is My Top Stock Pick Among the Weight Loss Industry Leaders
03:15am, Tuesday, 16'th Sep 2025
The new generation of effective weight loss drugs has generated billions of dollars for industry leaders Eli Lilly (LLY -0.96%) and Novo Nordisk (NVO 1.39%), and opened the door for companies such as
Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now?
12:11pm, Monday, 15'th Sep 2025
Eli Lilly shares move past the 50-day SMA as weight-loss drug data, rising sales and pipeline momentum fuel optimism.
Is Trending Stock Eli Lilly and Company (LLY) a Buy Now?
10:01am, Monday, 15'th Sep 2025
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
1 Stock That Should Be in Every Investor's Portfolio
06:15am, Monday, 15'th Sep 2025
It's not often that something as influential as an effective weight loss drug comes on the market. Eli Lilly (LLY -0.20%) has that product.
2 no-brainer stocks to buy for end of 2025
02:52pm, Sunday, 14'th Sep 2025
As investors position their portfolios for the next year, certain companies stand out for their strong fundamentals and long-term growth drivers.
3 Monster Stocks to Hold for the Next 5 Years
07:45am, Sunday, 14'th Sep 2025
The past five years have been rocky, to say the least. Investors have dealt with a worldwide pandemic, political tensions, trade wars, actual wars, economic troubles, market crashes, and more.
2 Beaten-Down Stocks to Buy and Hold Forever
07:45am, Saturday, 13'th Sep 2025
Apple (AAPL 1.82%) and Eli Lilly (LLY -0.20%) share several similarities. Both are long-standing leaders in their respective industries, having produced market-beating returns over the past 10 years,
3 No-Brainer Dividend Stocks to Buy in September
06:42am, Saturday, 13'th Sep 2025
Some decisions are tough to make. Others are so easy that they don't require much thought and are practically no-brainers.
Eli Lilly, Novo Nordisk prepare to face off in the next obesity drug battleground
12:13pm, Friday, 12'th Sep 2025
Eli Lilly and Novo Nordisk are both preparing to launch obesity pills in the U.S. next year. Lilly expects results from a head-to-head trial of its pill orforglipron versus Novo's oral semaglutide in
1 Super Stock Down More Than 20% to Buy Hand Over Fist, According to Wall Street
04:44am, Friday, 12'th Sep 2025
For a while, it seemed that nothing could go wrong for Eli Lilly (LLY 0.23%). Surging sales for Lilly's type 2 diabetes drug Mounjaro and great expectations for its obesity drug Zepbound fueled massiv
Eli Lilly loses appeal of $183.7 million Medicaid fraud award
01:30pm, Thursday, 11'th Sep 2025
A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a whistleblowing lawyer and pharmacist who accused the drugmaker of defrauding Medicaid.
Lilly to participate in Bernstein's 2nd Annual Healthcare Forum
10:00am, Thursday, 11'th Sep 2025
INDIANAPOLIS , Sept. 11, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Bernstein's 2nd Annual Healthcare Forum on September 25, 2025.
2 Monster Stocks to Hold for the Next 5 Years
04:20am, Thursday, 11'th Sep 2025
What's a monster stock? In my book, it's a company that's already delivered enormous growth to investors, and considering opportunities ahead, this player should continue to roar higher in the years t
Oxford Industries says new Lilly Pulitzer offerings are winning over shoppers, but its Tommy Bahama line is lagging
05:57pm, Wednesday, 10'th Sep 2025
Resort-style clothing maker Oxford Industries Inc. on Wednesday offered up mixed second-quarter results and third-quarter expectations, and said that while new Lilly Pulitzer offerings were attracting
